Additional file 1 of A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma

Additional file 1: Table S1. Detailed description of RCTs. RCT, randomized controlled trial; ITT, intention-to-treat; OS, overall survival; EFS, event-free survival; DFS, disease-free survival; VCR, vincristine; ActD, actinomycin D; CPA, cyclophosphamide; ADM (DOX), doxorubicin; IFM, ifosfamide; ETP, etoposide; VAC, VCR + ActD+CPA; VACA, VCR + ActD+CPA + ADM; VAIA, VCR + ActD+IFM + ADM; VAI, VCR + ActD+IFM; VDC, VCR + doxorubicin+CPA; IE, IFM + ETP; EVAIA, ETP + VCR + ActD+IFM + ADM.附加文件1：表S1。随机对照试验（RCT，randomized controlled trial）详细说明。意向性治疗分析（ITT，intention-to-treat）；总生存期（OS，overall survival）；无事件生存期（EFS，event-free survival）；无病生存期（DFS，disease-free survival）；长春新碱（VCR，vincristine）；放线菌素D（ActD，actinomycin D）；环磷酰胺（CPA，cyclophosphamide）；多柔比星（ADM (DOX)，doxorubicin）；异环磷酰胺（IFM，ifosfamide）；依托泊苷（ETP，etoposide）；VAC方案：长春新碱+放线菌素D+环磷酰胺；VACA方案：长春新碱+放线菌素D+环磷酰胺+多柔比星；VAIA方案：长春新碱+放线菌素D+异环磷酰胺+多柔比星；VAI方案：长春新碱+放线菌素D+异环磷酰胺；VDC方案：长春新碱+多柔比星+环磷酰胺；IE方案：异环磷酰胺+依托泊苷；EVAIA方案：依托泊苷+长春新碱+放线菌素D+异环磷酰胺+多柔比星。